Predicted to grow at a CAGR of 4.9% during the forecast period, the global Indian Heparin market is estimated to reach USD 170.2 Million by the end of 2022.
The Indian Heparin Market is projected to reach USD 883.0 million and USD 170.2 million by 2022, respectively.
Peptide and Anticoagulant Drugs Market by Type (Hormonal (Insulin, Teriparatide, Calcitonin), Antibioctic (Colistin, Cycloserine), Low molecular weight heparin (Enaxaparin Sodium, Heparin Sodium), Application (Diabetes, Cancer) - India Forecast to 2022
The Indian peptide drugs market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%.
The Indian Heparin market is expected to reach USD 883.0 Million in 2022 from USD 381.8 Million in 2016 and is expected to register a CAGR of 15.0%.
Increasing prevalence of chronic diseases such as cancer and diabetes and favorable government policies for the pharmaceutical sector are the major factors driving the growth of Indian peptides market.
Increasing prevalence of chronic diseases such as cancer and diabetes and favorable government policies for the pharmaceutical sector are the major factors driving the growth of Indian peptides market.
The Indian peptides market is projected to reach USD 883.0 Million by 2022 from USD 381.8 Million in 2016, at a CAGR of 15.0%.